GRITTI, GIUSEPPE

GRITTI, GIUSEPPE  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 40 (tempo di esecuzione: 0.034 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 01 - Articolo su rivista 2025 Lussana, FedericoMagnani, Chiara F.Galimberti, StefaniaGritti, GiuseppeBelotti, DanielaMoretti, AlexBuracchi, ChiaraRambaldi, BenedettaRizzuto, GiulianaPaganessi, MurielMeli, CristianTettamanti, SarahRisca, GiuliaSpinozzi, GiulioCazzaniga, GiovanniGotti, ElisaIntrona, MartinoBalduzzi, AdrianaValsecchi, Maria GraziaRambaldi, AlessandroBiondi, Andrea +
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma 01 - Articolo su rivista 2024 Gritti G. +
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences 01 - Articolo su rivista 2024 Gritti G. +
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma 01 - Articolo su rivista 2024 Gritti G. +
Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma 01 - Articolo su rivista 2024 Gritti G. +
Rapid immune reconstitution following the infusion of autologous, Blinatumomab Expanded T-cells (BET) in patients with B-cell indolent NHL or CLL 01 - Articolo su rivista 2024 Gritti G. +
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study 01 - Articolo su rivista 2024 Gritti G. +
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up 01 - Articolo su rivista 2023 Gritti G. +
Spleen tyrosine kinase/FMS-Like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/ CB-659 01 - Articolo su rivista 2023 Gritti G. +
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study 01 - Articolo su rivista 2023 Gritti G. +
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 01 - Articolo su rivista 2023 Gritti G. +
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia 01 - Articolo su rivista 2022 Gritti G. +
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study 01 - Articolo su rivista 2022 Gritti G. +
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 02 - Intervento a convegno 2022 Rambaldi, BenedettaGalimberti, StefaniaRizzuto, GiulianaMagnani, Chiara FrancescaBuracchi, ChiaraRisca, GiuliaParedi, MartinaBelotti, DanielaMoretti, AlexPonzo, MariannaTettamanti, SarahMeli, CristianPaganessi, MurielZaninelli, SilviaGotti, ElisaIntrona, MartinoLussana, FedericoGritti, GiuseppeBalduzzi, AdrianaValsecchi, Maria GraziaRambaldi, AlessandroBiondi, AndreaGaipa, Giuseppe +
Chimeric antigen receptor T cells for gamma–delta T cell malignancies 01 - Articolo su rivista 2022 Gritti G. +
DeepMIF: Deep Learning Based Cell Profiling for Multispectral Immunofluorescence Images with Graphical User Interface 02 - Intervento a convegno 2022 Gritti G. +
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis 01 - Articolo su rivista 2022 Gritti G.Bruno A. +
Genetic and phenotypic attributes of splenic marginal zone lymphoma 01 - Articolo su rivista 2022 Gritti G. +
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma 01 - Articolo su rivista 2022 Gritti G. +
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy 01 - Articolo su rivista 2022 Gritti G. +